Genestra Brands HMB
Natural health product licensed in Canada
- Other names
- Genestra Brands HMB Complex
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80051759
- Status
- Active licence
- Licence date
- 12 June 2014
- Revision date
- 25 October 2016
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Glutamine Source : L-Glutamine | 3.5 g | Not calculated |
| L-Leucine Source : L-Leucine | 300 mg | Not calculated |
| Bêta-hydroxy-bêta-méthylbutyrate de calcium Source : Calcium beta-hydroxy-beta-methyl butyrate | 0.75 g | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 250 UI | 6.25 mcg | Not calculated |
Non-medicinal ingredients
Thaumatine, Chlorure de sodium, Saveur de limonade, Saveur, Acide DL-malique, Citrate de potassium, Acide citrique, Saveur d'orange, Dextrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Mesures | 1 Tous les jours |
| Adultes | Not specified | 2 Mesures | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Dose 1 and 2: Helps restore plasma glutamine levels depleted after periods of physical stress. Dose 1 and 2: Helps to support immune system and digestive system health after periods of physical stress. Dose 1 and 2: May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD). Dose 1 and 2: L-Arginine is a non essential amino acid that is involved in protein synthesis. Dose 1 and 2: Provides essential branched chain amino acids (L-leucine, L-isoleucine, L- valine) involved in protein synthesis. Dose 1 and 2: A factor in the maintenance of good health. Dose 1 and 2: Helps in the development and maintenance of bones and teeth. Dose 1 and 2: Helps in the absorption and use of calcium and phosphorus. Dose 1 only: Enhances muscle strength in previously untrained individuals in combination with intense resistance training exercise. Dose 1 and 2: Source of (essential) amino acids involved in muscle protein synthesis. Dose 1 and 2: Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051759
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging